Clinical trials
Completed Obesity trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 14 |
| 2024 | 9 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 86 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 9 |
| Eli Lilly and Company | 7 |
| University of Adelaide | 7 |
| Zafgen, Inc. | 6 |
| University of Melbourne | 5 |
| Boehringer Ingelheim | 4 |
| AstraZeneca | 3 |
| Sanofi | 3 |
| Sciwind Biosciences APAC CO Pty. Ltd. | 3 |
| The University of Western Australia | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 86 |
| Overweight | 30 |
| Diabetes Mellitus, Type 2 | 16 |
| Insulin Resistance | 7 |
| Cardiovascular Diseases | 6 |
| Weight Loss | 5 |
| Dyslipidemias | 4 |
| Inflammation | 4 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Nutrition Disorders | 3 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.